{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:10:07Z","timestamp":1744211407148,"version":"3.40.3"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["SN COMPUT. SCI."],"DOI":"10.1007\/s42979-022-01492-4","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T15:02:35Z","timestamp":1671634955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC"],"prefix":"10.1007","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9751-1170","authenticated-orcid":false,"given":"Manaswita","family":"Saikia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruba K.","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jugal K.","family":"Kalita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"1492_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/0-387-29362-0","volume-title":"Bioinformatics and Computational Biology Solutions Using R and Bioconductor","author":"GK Smyth","year":"2005","unstructured":"Smyth GK, limma, Linear Models for Microarray Data. In: Gentleman R, Carey VJ, Huber W, Irizarry RA, Dudoit S, editors. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York, NY: Springer; 2005. p. 397\u2013420. https:\/\/doi.org\/10.1007\/0-387-29362-0."},{"issue":"9","key":"1492_CR2","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci. 2001;98(9):5116\u201321. https:\/\/doi.org\/10.1073\/pnas.091062498.","journal-title":"Proc Natl Acad Sci."},{"issue":"456","key":"1492_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1198\/016214501753382129","volume":"96","author":"B Efron","year":"2001","unstructured":"Efron B, Tibshirani R, Storey JD, Tusher V. Empirical Bayes analysis of a microarray experiment. J Am Stat Assoc. 2001;96(456):1151\u201360. https:\/\/doi.org\/10.1198\/016214501753382129.","journal-title":"Journal of the American statistical association."},{"issue":"2","key":"1492_CR4","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29. https:\/\/doi.org\/10.1186\/gb-2014-15-2-r29.","journal-title":"Genome Biol."},{"issue":"1","key":"1492_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616.","journal-title":"Bioinformatics."},{"issue":"12","key":"1492_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol."},{"key":"1492_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinform."},{"issue":"5586","key":"1492_CR8","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1073374","volume":"297","author":"E Ravasz","year":"2002","unstructured":"Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barab\u00e1si AL. Hierarchical organization of modularity in metabolic networks. Science. 2002;297(5586):1551\u20135. https:\/\/doi.org\/10.1126\/science.1073374.","journal-title":"Science."},{"issue":"1","key":"1492_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1001057","volume":"7","author":"P Langfelder","year":"2011","unstructured":"Langfelder P, Luo R, Oldham MC, Horvath S. Is My Network Module Preserved and Reproducible? PLoS Comput Biol. 2011;7(1): https:\/\/doi.org\/10.1371\/journal.pcbi.1001057.","journal-title":"PLoS Comput Biol."},{"issue":"1","key":"1492_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"BT Sherman","year":"2009","unstructured":"Sherman BT, Lempicki RA, et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211.","journal-title":"Nat Protoc."},{"issue":"1","key":"1492_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1\u201313. https:\/\/doi.org\/10.1093\/nar\/gkn923.","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"1492_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.trecan.2015.07.001","volume":"1","author":"AS Bhagwat","year":"2015","unstructured":"Bhagwat AS, Vakoc CR. Targeting Transcription Factors in Cancer. Trends Cancer. 2015;1(1):53\u201365. https:\/\/doi.org\/10.1016\/j.trecan.2015.07.001.","journal-title":"Trends Cancer."},{"issue":"1","key":"1492_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12014-019-9232-6","volume":"16","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Qi X, Yu C, Yu S, Zhang C, Zhang Y, et al. Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB). Clin Proteomics. 2019;16(1):12. https:\/\/doi.org\/10.1186\/s12014-019-9232-6.","journal-title":"Clinical Proteomics."},{"key":"1492_CR14","doi-asserted-by":"publisher","unstructured":"Tang P, Jia R, Gong L, Sui Z, Xiao W, Yang Y, Gong L, Sui Z, Xiao W, Yang Y, Wu X and Yu Z, Zhang, H. High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor progression and poor prognosis. Res Square; 2022. https:\/\/doi.org\/10.21203\/rs.3.rs-554718\/v2.","DOI":"10.21203\/rs.3.rs-554718\/v2"},{"issue":"2","key":"1492_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s13277-014-2701-7","volume":"36","author":"W Jiang","year":"2015","unstructured":"Jiang W, Yao F, He J, Lv B, Fang W, Zhu W, He G, Chen J, He J. Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma. Tumor Biol 2015;36(2):1289\u201397. https:\/\/doi.org\/10.1007\/s13277-014-2701-7.","journal-title":"Tumor Biology"},{"issue":"4","key":"1492_CR16","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.3892\/ol.2016.4947","volume":"12","author":"TY Shen","year":"2016","unstructured":"Shen TY, Mei LL, Qiu YT, Shi ZZ. Identification of candidate target genes of genomic aberrations in esophageal squamous cell carcinoma. Oncol Lett. 2016;12(4):2956\u20132961. https:\/\/doi.org\/10.3892\/ol.2016.4947.","journal-title":"Oncol Lett"},{"issue":"10","key":"1492_CR17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/kjm2.12093","volume":"35","author":"AG Ma","year":"2019","unstructured":"Ma AG, Yu LM, Zhao H, Qin CW, Tian XY, Wang Q. PSMD4 regulates the malignancy of esophageal cancer cells by suppressing endoplasmic reticulum stress. Kaohsiung J Med Sci. 2019;35(10):591\u2013597. https:\/\/doi.org\/10.1002\/kjm2.12093.","journal-title":"Kaohsiung J Med Sci"},{"issue":"3","key":"1492_CR18","doi-asserted-by":"publisher","first-page":"e89956","DOI":"10.1371\/journal.pone.0089956","volume":"9","author":"WC Chen","year":"2014","unstructured":"Chen WC, Chen MF, Lin PY. Significance of DNMT3b in oral cancer. PLoS One. 2014;9(3):e89956. https:\/\/doi.org\/10.1371\/journal.pone.0089956.","journal-title":"PLoS One"},{"issue":"1","key":"1492_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000445633","volume":"39","author":"B Liu","year":"2016","unstructured":"Liu B, Jia Y, Cao Y, Wu S, Jiang H, Sun X, et al. Overexpression of Phosphoserine Aminotransferase 1 (PSAT1) Predicts Poor Prognosis and Associates with Tumor Progression in Human Esophageal Squamous Cell Carcinoma. Cell Physiol Biochem. 2016;39(1):395\u2013406.https:\/\/doi.org\/10.1159\/000445633 .","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"1492_CR20","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3892\/or.2018.6334","volume":"39","author":"R Cheng","year":"2018","unstructured":"Cheng R, Zhu S, Guo S, Min L, Xing J, Guo Q, Li P, Zhang S. Downregulation of NONO induces apoptosis, suppressing growth and invasion in esophageal squamous cell carcinoma. Oncol Rep. 2018;39(6):2575\u20132583. https:\/\/doi.org\/10.3892\/or.2018.6334.","journal-title":"Oncol Rep"},{"issue":"7","key":"1492_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1245\/ASO.2006.08.006","volume":"13","author":"S Wada","year":"2006","unstructured":"Wada S, Noguchi T, Takeno S, Kawahara K. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma. Ann Surg Oncol. 2006;13(7):961\u20136. https:\/\/doi.org\/10.1245\/ASO.2006.08.006.","journal-title":"Ann Surg Oncol"},{"key":"1492_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.humpath.2017.06.003","volume":"66","author":"JZ He","year":"2017","unstructured":"He JZ, Wu ZY, Wang SH, Ji X, Yang CX, Xu XE, et al. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma. Hum Pathol. 2017;66:115\u2013125. https:\/\/doi.org\/10.1016\/j.humpath.2017.06.003.","journal-title":"Hum Pathol"},{"issue":"1","key":"1492_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3442-y","volume":"17","author":"X Yu","year":"2017","unstructured":"Yu X, Li W, Xia Z, Xie L, Ma X, Liang Q, Liu L, Wang J, Zhou X, Yang Y, Liu H. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis. BMC Cancer. 2017;17(1):449. https:\/\/doi.org\/10.1186\/s12885-017-3442-y.","journal-title":"BMC Cancer"},{"key":"1492_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.715027","volume":"9","author":"X Yang","year":"2021","unstructured":"Yang X, Han B, He Z, Zhang Y, Lin K, Su H, Hosseini DK, Sun H, Yang M, Chen X. RNA-Binding Proteins CLK1 and POP7 as Biomarkers for Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol. 2021;9:715027. https:\/\/doi.org\/10.3389\/fcell.2021.715027.","journal-title":"Front Cell Dev Biol."},{"issue":"6","key":"1492_CR25","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.3892\/or.2017.5614","volume":"37","author":"YT Qiu","year":"2017","unstructured":"Qiu YT, Wang WJ, Zhang B, Mei LL, Shi ZZ. MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1\/mTOR signaling pathway. Oncol Rep. 2017;37(6):3590\u20133596. https:\/\/doi.org\/10.3892\/or.2017.5614.","journal-title":"Oncol Rep"},{"key":"1492_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.humpath.2016.07.013","volume":"57","author":"B Choy","year":"2016","unstructured":"Choy B, LaLonde A, Que J, Wu T, Zhou Z. MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions. Hum Pathol. 2016;57:126\u2013135. https:\/\/doi.org\/10.1016\/j.humpath.2016.07.013.","journal-title":"Hum Pathol"},{"issue":"2","key":"1492_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/his.12456","volume":"66","author":"X Zhong","year":"2015","unstructured":"Zhong X, Chen X, Guan X, Zhang H, Ma Y, Zhang S, Wang E, Zhang L, Han Y. Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis. Histopathology. 2015;66(2):192\u2013200. https:\/\/doi.org\/10.1111\/his.12456.","journal-title":"Histopathology"},{"issue":"5","key":"1492_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/ijc.10860","volume":"103","author":"T Miyazaki","year":"2003","unstructured":"Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer. 2003;103(5):657\u201363. https:\/\/doi.org\/10.1002\/ijc.10860.","journal-title":"Int J Cancer"},{"issue":"4","key":"1492_CR29","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3892\/or.2014.3381","volume":"32","author":"S Ma","year":"2014","unstructured":"Ma S, Zhao X. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation. Oncol Rep. 2014;32(4):1631\u20137. https:\/\/doi.org\/10.3892\/or.2014.3381.","journal-title":"Oncol Rep"},{"issue":"3","key":"1492_CR30","first-page":"851","volume":"30","author":"M Sakai","year":"2010","unstructured":"Sakai M, Sohda M, Miyazaki T, Suzuki S, Sano A, Tanaka N, et al. Significance of karyopherin-$$\\alpha$$ 2 (KPNA2) expression in esophageal squamous cell carcinoma. Anticancer Res. 2010;30(3):851\u20136.","journal-title":"Anticancer Res"},{"issue":"21","key":"1492_CR31","doi-asserted-by":"publisher","first-page":"24050","DOI":"10.18632\/aging.203585","volume":"13","author":"L Wang","year":"2021","unstructured":"Wang L, Liu G, Bolor-Erdene E, Li Q, Mei Y, Zhou L. Identification of KIF4A as a prognostic biomarker for esophageal squamous cell carcinoma. Aging (Albany NY). 2021;13(21):24050\u201324070. https:\/\/doi.org\/10.18632\/aging.203585.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"1492_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/1759-7714.13787","volume":"12","author":"X Sun","year":"2021","unstructured":"Sun X, Chen P, Chen X, Yang W, Chen X, Zhou W, Chen X, Zhou W, Huang D, Cheng Y. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma. Thorac Cancer. 2021;12(4):512\u2013524. https:\/\/doi.org\/10.1111\/1759-7714.13787.","journal-title":"Thorac Cancer"},{"issue":"5","key":"1492_CR33","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3892\/or.2014.3062","volume":"31","author":"Y Kita","year":"2014","unstructured":"Kita Y, Nishizono Y, Okumura H, Uchikado Y, Sasaki K, Matsumoto M, Setoyama T, Tanoue K, Omoto I, Mori S, Owaki T, Ishigami S, Nakagawa H, Tanaka F, Mimori K, Mori M, Natsugoe S. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma. Oncol Rep. 2014; 31(5):1986\u201392. https:\/\/doi.org\/10.3892\/or.2014.3062.","journal-title":"Oncol Rep"},{"issue":"12","key":"1492_CR34","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1007\/s10620-010-1212-7","volume":"55","author":"X Zheng","year":"2010","unstructured":"Zheng X, Zhao Y, Wang X, Li Y, Wang R, Jiang Y, Gong T, Li M, Sun L, Hong L, Li X, Liang J, Luo G, Jin B, Yang J, Zhang H, Fan D. Decreased expression of CIAPIN1 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Dig Dis Sci. 2010; 55(12):3408\u201314. https:\/\/doi.org\/10.1007\/s10620-010-1212-7.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"1492_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1595-0","volume":"10","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Lu Q, Li C, Wang X, Jiang L, Huang L, Wang C, Chen H. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation. Cell Death Dis. 2019; 10(5):359. https:\/\/doi.org\/10.1038\/s41419-019-1595-0.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1492_CR36","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s13277-015-4098-3","volume":"37","author":"W Zhou","year":"2016","unstructured":"Zhou W, Yue H, Li C, Chen H, Yuan Y. Protein arginine methyltransferase 1 promoted the growth and migration of cancer cells in esophageal squamous cell carcinoma. Tumour Biol. 2016; 37(2):2613\u20139. https:\/\/doi.org\/10.1007\/s13277-015-4098-3.","journal-title":"Tumor Biol"},{"issue":"1","key":"1492_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ijc.27621","volume":"132","author":"X Zhang","year":"2013","unstructured":"Zhang X, Lin A, Zhang JG, Bao WG, Xu DP, Ruan YY, Yan WH. Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma. Int J Cancer. 2013; 132(1):82\u20139. https:\/\/doi.org\/10.1002\/ijc.27621.","journal-title":"Int J Cancer"},{"issue":"6","key":"1492_CR38","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1309\/JNCW1QLDFB6AM9WE","volume":"128","author":"Sm Yie","year":"2007","unstructured":"Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol. 2007;128(6):1002\u20139. https:\/\/doi.org\/10.1309\/JNCW1QLDFB6AM9WE.\u00a0","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"1492_CR39","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1245\/s10434-015-4909-1","volume":"23","author":"Y Sato","year":"2016","unstructured":"Sato Y, Motoyama S, Nanjo H, Wakita A, Yoshino K, Sasaki T, Nagaki Y, Liu J, Imai K, Saito H, Minamiya Y. CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2016;23(3):936-42. https:\/\/doi.org\/10.1245\/s10434-015-4909-1.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1492_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yexcr.2018.03.017","volume":"367","author":"H Yuan","year":"2018","unstructured":"Yuan H, Zhou W, Yang Y, Xue L, Liu L, Song Y. ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET\/Fyn\/\u03b2-catenin signaling pathway. Exp Cell Res. 2018; 367(1):47-55. https:\/\/doi.org\/10.1016\/j.yexcr.2018.03.017.","journal-title":"Exp Cell Res"},{"issue":"1","key":"1492_CR41","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3892\/ol.2019.11077","volume":"19","author":"H Yu","year":"2020","unstructured":"Yu H, Yao J, Du M, Ye J, He X, Yin L. CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma. Oncol Lett. 2020;19(1):542-548. https:\/\/doi.org\/10.3892\/ol.2019.11077.","journal-title":"Oncol Lett"},{"issue":"1","key":"1492_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13019-021-01534-7","volume":"16","author":"W Wang","year":"2021","unstructured":"Wang W, Liao K, Guo HC, Zhou S, Yu R, Liu Y, Pan Y, Pu J. Integrated transcriptomics explored the cancer-promoting genes CDKN3 in esophageal squamous cell cancer. J Cardiothorac Surg. 2021;16(1):148. https:\/\/doi.org\/10.1186\/s13019-021-01534-7.\u00a0","journal-title":"J Cardiothorac Surg"},{"issue":"8","key":"1492_CR43","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.7150\/jca.27053","volume":"10","author":"J Liu","year":"2019","unstructured":"Liu J, Min L, Zhu S, Guo Q, Li H, Zhang Z, Zhao Y, Xu C, Zhang S. Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma. J Cancer. 2019; 10(8):1915-1922. https:\/\/doi.org\/10.7150\/jca.27053.","journal-title":"J Cancer"},{"issue":"6","key":"1492_CR44","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.21037\/jtd.2020.01.33","volume":"12","author":"J Hu","year":"2020","unstructured":"Hu J, Li R, Miao H, Wen Z. Identification of key genes for esophageal squamous cell carcinoma via integrated bioinformatics analysis and experimental confirmation. J Thorac Dis. 2020; 12(6):3188-3199. https:\/\/doi.org\/10.21037\/jtd.2020.01.33.","journal-title":"J Thorac Dis"},{"issue":"39","key":"1492_CR45","doi-asserted-by":"publisher","first-page":"65642","DOI":"10.18632\/oncotarget.20020","volume":"8","author":"ZC Liu","year":"2017","unstructured":"Liu ZC, Cao K, Xiao ZH, Qiao L, Wang XQ, Shang B, Jia Y, Wang Z. VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma. Oncotarget. 2017; 8(39):65642-65658. https:\/\/doi.org\/10.18632\/oncotarget.20020.","journal-title":"Oncotarget"},{"issue":"2","key":"1492_CR46","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/eji.202149441","volume":"52","author":"J Liu","year":"2022","unstructured":"Liu J, Shao J, Zhang C, Qin G, Liu J, Li M, Wu P, Zhao X, Zhang Y. Immuno-oncological role of 20S proteasome alpha-subunit 3 in aggravating the progression of esophageal squamous cell carcinoma. Eur J Immunol. 2022; 52(2):338-351. https:\/\/doi.org\/10.1002\/eji.202149441.","journal-title":"Eur J Immunol"},{"issue":"10","key":"1492_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-04155-z","volume":"12","author":"F Wang","year":"2021","unstructured":"Wang F, Zhang C, Cheng H, Liu C, Lu Z, Zheng S, Wang S, Sun N, He J. TGF-\u03b2-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2. Cell Death Dis. 2021 Oct 2;12(10):901. https:\/\/doi.org\/10.1038\/s41419-021-04155-z.","journal-title":"Cell Death Dis"},{"key":"1492_CR48","doi-asserted-by":"publisher","first-page":"107616","DOI":"10.1016\/j.intimp.2021.107616","volume":"96","author":"J Qu","year":"2021","unstructured":"Qu J, Zhao Q, Yang L, Ping Y, Zhang K, Lei Q, Liu F, Zhang Y. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma. Int Immunopharmacol. 2021; 96:107616. https:\/\/doi.org\/10.1016\/j.intimp.2021.107616.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1492_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-791","volume":"14","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Molavi O, Su M, Lai R. The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma. BMC Cancer. 2014; 14:791. https:\/\/doi.org\/10.1186\/1471-2407-14-791 .","journal-title":"BMC Cancer"},{"issue":"2","key":"1492_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4103\/jcrt.JCRT_781_19","volume":"16","author":"N Shao","year":"2020","unstructured":"Shao N, Han Y, Song L, Song W. Clinical significance of hypoxia-inducible factor 1\u03b1, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma. J Cancer Res Ther. 2020;16(2):269-275. https:\/\/doi.org\/10.4103\/jcrt.JCRT_781_19.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"1492_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7150\/jca.35537","volume":"11","author":"X Hu","year":"2020","unstructured":"Hu X, Lin J, Jiang M, He X, Wang K, Wang W, Hu C, Shen Z, He Z, Lin H, Wu D, Wang M. HIF-1\u03b1 Promotes the Metastasis of Esophageal Squamous Cell Carcinoma by Targeting SP1. J Cancer. 2020; 11(1):229-240. https:\/\/doi.org\/10.7150\/jca.35537.","journal-title":"J Cancer"},{"issue":"1","key":"1492_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-68713-9","volume":"10","author":"D Bolidong","year":"2020","unstructured":"Bolidong D, Domoto T, Uehara M, Sabit H, Okumura T, Endo Y, Nakada M, Ninomiya I, Miyashita T, Wong RW, Minamoto T. Potential therapeutic effect of targeting glycogen synthase kinase 3\u03b2 in esophageal squamous cell carcinoma. Sci Rep. 2020; 10(1):11807. https:\/\/doi.org\/10.1038\/s41598-020-68713-9.","journal-title":"Sci Rep"},{"issue":"10","key":"1492_CR53","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1002\/mc.22685","volume":"56","author":"S Gao","year":"2017","unstructured":"Gao S, Li S, Duan X, Gu Z, Ma Z, Yuan X, Feng X, Wang H. Inhibition of glycogen synthase kinase 3 beta (GSK3\u03b2) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity. Mol Carcinog. 2017; 56(10):2301-2316. https:\/\/doi.org\/10.1002\/mc.22685.","journal-title":"Mol Carcinog"},{"issue":"4","key":"1492_CR54","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/cncr.10329","volume":"94","author":"K Kato","year":"2002","unstructured":"Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, Okushiba S, Kondo S, Katoh H. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer. 2002; 94(4):929-33. https:\/\/doi.org\/10.1002\/cncr.10329.","journal-title":"Cancer"},{"issue":"3","key":"1492_CR55","first-page":"601","volume":"18","author":"T Ando","year":"2007","unstructured":"Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, Tomoda K, Mori R, Harada K, Katada T, Ogawa R, Fujii Y, Kuwabara Y. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol Rep. 2007;18(3):601-9.","journal-title":"Oncol Rep"},{"issue":"4","key":"1492_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11177","volume":"23","author":"F Lu","year":"2022","unstructured":"Lu F, Chen W, Jiang T, Cheng C, Wang B, Lu Z, Huang G, Qiu J, Wei W, Yang M, Huang X. Expression profile, clinical significance and biological functions of IGF2BP2 in esophageal squamous cell carcinoma. Exp Ther Med. 2022; 23(4):252. https:\/\/doi.org\/10.3892\/etm.2022.11177.","journal-title":"Exp Ther Med"},{"key":"1492_CR57","doi-asserted-by":"publisher","unstructured":"Shu W, Lin Y, Yan Y, Sun Y, Wu X, Cao Q. IGF2BP2 Promotes the Proliferation, Invasion and Migration of Esophageal Carcinoma Cells via Activation of the PI3K\/AKT\/EMT Signaling Pathway. Research Square; 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-711778\/v1.","DOI":"10.21203\/rs.3.rs-711778\/v1"},{"issue":"1","key":"1492_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-9966-29-83","volume":"29","author":"T Tanaka","year":"2010","unstructured":"Tanaka T, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Katada T, Shiozaki M, Naganawa Y, Fujii Y, Takeyama H. Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis. J Exp Clin Cancer Res. 2010; 29(1):83. https:\/\/doi.org\/10.1186\/1756-9966-29-83.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"1492_CR59","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3892\/or.10.6.1747","volume":"10","author":"Y Kimura","year":"2003","unstructured":"Kimura Y, Watanabe M, Ohga T, Saeki H, Kakeji Y, Baba H, Maehara Y. Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep. 2003; 10(6):1747-51. https:\/\/doi.org\/10.3892\/or.10.6.1747.","journal-title":"Oncol Rep"},{"issue":"11","key":"1492_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0979-x","volume":"9","author":"YF Feng","year":"2018","unstructured":"Feng YF, Lei YY, Lu JB, Xi SY, Zhang Y, Huang QT, Wu QL, Wang F. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis. Cell Death Dis. 2018; 9(11):1085. https:\/\/doi.org\/10.1038\/s41419-018-0979-x.","journal-title":"Cell Death Dis"},{"issue":"8","key":"1492_CR61","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/onc.2017.383","volume":"37","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Wang L, Ban X, Zeng T, Zhu Y, Li M, Guan XY, Li Y. DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma. Oncogene. 2018; 37(8):1086-1094. https:\/\/doi.org\/10.1038\/onc.2017.383.","journal-title":"Oncogene"},{"issue":"19","key":"1492_CR62","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1158\/0008-5472.CAN-10-4291","volume":"71","author":"Y Li","year":"2011","unstructured":"Li Y, Chen L, Nie CJ, Zeng TT, Liu H, Mao X, Qin Y, Zhu YH, Fu L, Guan XY. Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma. Cancer Res. 2011; 71(19):6106-15. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4291.","journal-title":"Cancer Res"},{"key":"1492_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.632531","volume":"27","author":"X Wang","year":"2021","unstructured":"Wang X, Liu Y, Leng X, Cao K, Sun W, Zhu J, Ma J. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma. Pathol. Oncol. Res. 2021;27: https:\/\/doi.org\/10.3389\/pore.2021.632531.","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"1492_CR64","first-page":"345","volume":"8","author":"J Gao","year":"2015","unstructured":"Gao J, Zou Z, Gao J, Zhang H, Lin Z, Zhang Y, Luo X, Liu C, Xie J, Cai C. Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2015; 8(1):345-52.","journal-title":"Int J Clin Exp Pathol"},{"key":"1492_CR65","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fgene.2021.616110","volume":"12","author":"J Huang","year":"2021","unstructured":"Huang J, Wang X, Zhang X, Chen W, Luan L, Song Q, Wang H, Liu J, Xu L, Xu Y, Shen L, Tan L, Jiang D, Su J, Hou Y. CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome. Front Genet. 2021; 12:616110. https:\/\/doi.org\/10.3389\/fgene.2021.616110.","journal-title":"Front Genet"},{"issue":"4","key":"1492_CR66","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ejso.2012.01.008","volume":"38","author":"Z Ling","year":"2012","unstructured":"Ling ZQ, Zhao Q, Zhou SL, Mao WM. MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma. Eur J Surg Oncol. 2012; 38(4):326-32.\u00a0 https:\/\/doi.org\/10.1016\/j.ejso.2012.01.008.","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"1492_CR67","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.2147\/OTT.S298620","volume":"14","author":"Y Xu","year":"2021","unstructured":"Xu Y, Wang N, Liu R, Lv H, Li Z, Zhang F, Gai C, Tian Z. Epigenetic Study of Esophageal Carcinoma Based on Methylation, Gene Integration and Weighted Correlation Network Analysis. Onco Targets Ther. 2021; 14:3133-3149. https:\/\/doi.org\/10.2147\/OTT.S298620.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"1492_CR68","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3892\/ijo.2018.4639","volume":"54","author":"X Chen","year":"2019","unstructured":"Chen X, Lu B, Ma Q, Ji CD, Li JZ. EphA3 inhibits migration and invasion of esophageal cancer cells by activating the mesenchymal\u2011epithelial transition process. Int J Oncol. 2019; 54(2):722-732. https:\/\/doi.org\/10.3892\/ijo.2018.4639.","journal-title":"Int J Oncol"},{"issue":"1","key":"1492_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep17336","volume":"5","author":"LL Luo","year":"2015","unstructured":"Luo LL, Zhao L, Wang YX, Tian XP, Xi M, Shen JX, He LR, Li QQ, Liu SL, Zhang P, Xie D, Liu MZ. Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma. Sci Rep. 2015; 5(1):17336. https:\/\/doi.org\/10.1038\/srep17336.","journal-title":"Sci Rep"},{"issue":"4","key":"1492_CR70","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s13277-012-0352-0","volume":"33","author":"L Zhao","year":"2012","unstructured":"Zhao L, Li QQ, Zhang R, Xi M, Liao YJ, Qian D, He LR, Zeng YX, Xie D, Liu MZ. The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin. Tumour Biol. 2012; 33(4):1115-23. https:\/\/doi.org\/10.1007\/s13277-012-0352-0.","journal-title":"Tumor Biol"},{"issue":"3","key":"1492_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-015-0046-2","volume":"34","author":"LL Luo","year":"2015","unstructured":"Luo LL, Zhao L, Xi M, He LR, Shen JX, Li QQ, Liu SL, Zhang P, Xie D, Liu MZ. Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma. Chin J Cancer. 2015; 34(11):514-21. https:\/\/doi.org\/10.1186\/s40880-015-0046-2.","journal-title":"Chin J Cancer"},{"issue":"1","key":"1492_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3892\/or.2019.7395","volume":"43","author":"X Wang","year":"2020","unstructured":"Wang X, Cheng G, Zhang T, Deng L, Xu K, Xu X, Wang W, Zhou Z, Feng Q, Chen D, Bi N, Wang L. CHST15 promotes the proliferation of TE\u20111 cells via multiple pathways in esophageal cancer. Oncol Rep. 2020; 43(1):75-86. https:\/\/doi.org\/10.3892\/or.2019.7395.","journal-title":"Oncol Rep"},{"issue":"5","key":"1492_CR73","doi-asserted-by":"publisher","first-page":"e19213","DOI":"10.1371\/journal.pone.0019213","volume":"6","author":"SC Tripathi","year":"2011","unstructured":"Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, Dattagupta S, Sharma MC, Ralhan R, Siu KW. Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer. PLoS One. 2011; 6(5):e19213. https:\/\/doi.org\/10.1371\/journal.pone.0019213.","journal-title":"PLoS One"},{"issue":"4","key":"1492_CR74","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/gcc.20539","volume":"47","author":"KD Tan","year":"2008","unstructured":"Tan KD, Zhu Y, Tan HK, Rajasegaran V, Aggarwal A, Wu J, Wu HY, Hwang J, Lim DT, Soo KC, Tan P. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma. Genes Chromosomes Cancer. 2008; 47(4):353-62. https:\/\/doi.org\/10.1002\/gcc.20539.","journal-title":"Genes Chromosom Cancer"},{"issue":"2","key":"1492_CR75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/0975-8844.143049","volume":"6","author":"NH Al-Rawi","year":"2014","unstructured":"Al-Rawi NH, Merza MS, Ghazi AM, et al. PIK3CB and K-ras in oral squamous Cell carcinoma. A possible cross-talk! J Orofac Sci. 2014;6(2):99.","journal-title":"J Orofac Sci"},{"issue":"14","key":"1492_CR76","doi-asserted-by":"publisher","first-page":"7039","DOI":"10.1111\/jcmm.16717","volume":"25","author":"Y Liang","year":"2021","unstructured":"Liang Y, Lei Y, Du M, Liang M, Liu Z, Li X, Gao Y. The increased expression and aberrant methylation of SHC1 in non-small cell lung cancer: Integrative analysis of clinical and bioinformatics databases. J Cell Mol Med. 2021; 25(14):7039-7051. https:\/\/doi.org\/10.1111\/jcmm.16717.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1492_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-016-0070-1","volume":"6","author":"H Xue","year":"2016","unstructured":"Xue H, Lu J, Yuan R, Liu J, Liu Y, Wu K, Wu J, Du J, Shen B. Knockdown of CLIC4 enhances ATP-induced HN4 cell apoptosis through mitochondrial and endoplasmic reticulum pathways. Cell Biosci. 2016;6:5. https:\/\/doi.org\/10.1186\/s13578-016-0070-1.\u00a0","journal-title":"Cell Biosci"},{"issue":"16","key":"1492_CR78","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1002\/cncr.26736","volume":"118","author":"MF Chen","year":"2012","unstructured":"Chen MF, Lu MS, Lin PY, Chen PT, Chen WC, Lee KD. The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma. Cancer. 2012;118(16):4074-89. https:\/\/doi.org\/10.1002\/cncr.26736.","journal-title":"Cancer"},{"issue":"1","key":"1492_CR79","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2008.03.034","volume":"268","author":"Z Liu","year":"2008","unstructured":"Liu Z, Wang L, Wang LE, Sturgis EM, Wei Q. Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2008; 268(1):158-65. https:\/\/doi.org\/10.1016\/j.canlet.2008.03.034.","journal-title":"Cancer Lett"},{"issue":"4","key":"1492_CR80","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1158\/1541-7786.MCR-14-0410","volume":"13","author":"G Ohmura","year":"2015","unstructured":"Ohmura G, Tsujikawa T, Yaguchi T, Kawamura N, Mikami S, Sugiyama J, Nakamura K, Kobayashi A, Iwata T, Nakano H, Shimada T, Hisa Y, Kawakami Y. Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC. Mol Cancer Res. 2015; 13(4):721-31. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0410.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"1492_CR81","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jop.13132","volume":"50","author":"J Liang","year":"2021","unstructured":"Liang J, Sun Z. Overexpression of membranal SLC3A2 regulates the proliferation of oral squamous cancer cells and affects the prognosis of oral cancer patients. J Oral Pathol Med. 2021; 50(4):371-377. https:\/\/doi.org\/10.1111\/jop.13132.","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"1492_CR82","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3892\/or_00000107","volume":"20","author":"X Ding","year":"2008","unstructured":"Ding X, Sun J, Wang L, Li G, Shen Y, Zhou X, Chen W. Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation. Oncol Rep. 2008 Nov;20(5):1041-5.\u00a0 https:\/\/doi.org\/10.3892\/or_00000107.","journal-title":"Oncol Rep"},{"issue":"5","key":"1492_CR83","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.21873\/invivo.12048","volume":"34","author":"S Ueda","year":"2020","unstructured":"Ueda S, Hashimoto K, Miyabe S, Hasegawa S, Goto M, Shimizu D, Oh-Iwa I, Shimozato K, Nagao T, Nomoto S. Salivary NUS1 and RCN1 Levels as Biomarkers for Oral Squamous Cell Carcinoma Diagnosis. In Vivo. 2020; 34(5):2353-2361. https:\/\/doi.org\/10.21873\/invivo.12048.","journal-title":"In Vivo"},{"issue":"4","key":"1492_CR84","first-page":"1514","volume":"7","author":"MH Zhu","year":"2014","unstructured":"Zhu MH, Ji SL, Zhang CY, Cui L, Xiong L, Zheng HL. DNA microarray reveals ZNF195 and SBF1 are potential biomarkers for gemcitabine sensitivity in head and neck squamous cell carcinoma cell lines. Int J Clin Exp Pathol. 2014;7(4):1514-23.","journal-title":"Int J Clin Exp Pathol"},{"issue":"18","key":"1492_CR85","doi-asserted-by":"publisher","first-page":"16623","DOI":"10.18632\/oncotarget.3932","volume":"6","author":"S Maji","year":"2015","unstructured":"Maji S, Samal SK, Pattanaik L, Panda S, Quinn BA, Das SK, Sarkar D, Pellecchia M, Fisher PB, Dash R. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas. Oncotarget. 2015; 6(18):16623-37. https:\/\/doi.org\/10.18632\/oncotarget.3932.","journal-title":"Oncotarget"},{"issue":"6A","key":"1492_CR86","first-page":"3763","volume":"28","author":"CJ Feng","year":"2008","unstructured":"Feng CJ, Li HJ, Li JN, Lu YJ, Liao GQ. Expression of Mcm7 and Cdc6 in oral squamous cell carcinoma and precancerous lesions. Anticancer Res. 2008; 28(6A):3763-9.","journal-title":"Anticancer Res"},{"issue":"19","key":"1492_CR87","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.7150\/jca.33368","volume":"10","author":"H Ma","year":"2019","unstructured":"Ma H, Li L, Jia L, Gong A, Wang A, Zhang L, Gu M, Tang G. POM121 is identified as a novel prognostic marker of oral squamous cell carcinoma. J Cancer. 2019; 10(19):4473-4480. https:\/\/doi.org\/10.7150\/jca.33368.","journal-title":"J Cancer"},{"issue":"5","key":"1492_CR88","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/15384101.2021.2021722","volume":"21","author":"Z Wang","year":"2022","unstructured":"Wang Z, Xiong H, Zuo Y, Hu S, Zhu C, Min A. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K\/Akt pathway. Cell Cycle. 2022; 21(5):477-488. https:\/\/doi.org\/10.1080\/15384101.2021.2021722.","journal-title":"Cell Cycle"},{"issue":"24","key":"1492_CR89","doi-asserted-by":"publisher","first-page":"18575","DOI":"10.1074\/jbc.M109.075085","volume":"285","author":"L Faoro","year":"2010","unstructured":"Faoro L, Singleton PA, Cervantes GM, Lennon FE, Choong NW, Kanteti R, Ferguson BD, Husain AN, Tretiakova MS, Ramnath N, Vokes EE, Salgia R. EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation. J Biol Chem. 2010; 285(24):18575-85. https:\/\/doi.org\/10.1074\/jbc.M109.075085.\u00a0","journal-title":"J Biol Chem"},{"issue":"5","key":"1492_CR90","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00432-010-0936-2","volume":"137","author":"Y Liu","year":"2011","unstructured":"Liu Y, Zhang X, Qiu Y, Huang D, Zhang S, Xie L, Qi L, Yu C, Zhou X, Hu G, Tian Y. Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck. J Cancer Res Clin Oncol. 2011; 137(5):761-9. https:\/\/doi.org\/10.1007\/s00432-010-0936-2.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"1492_CR91","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3892\/or.19.5.1079","volume":"19","author":"RS Rivera","year":"2008","unstructured":"Rivera RS, Gunduz M, Nagatsuka H, Gunduz E, Cengiz B, Fukushima K, Beder LB, Pehlivan D, Yamanaka N, Shimizu K, Nagai N. Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies. Oncol Rep. 2008;19(5):1079-84.\u00a0https:\/\/doi.org\/10.3892\/or.19.5.1079.","journal-title":"Oncol Rep"},{"issue":"1","key":"1492_CR92","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3892\/or.2018.6451","volume":"40","author":"F Lin","year":"2018","unstructured":"Lin F, Gao L, Su Z, Cao X, Zhan Y, Li Y, Zhang B. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation. Oncol Rep. 2018; 40(1):179-194. https:\/\/doi.org\/10.3892\/or.2018.6451.","journal-title":"Oncol Rep"},{"issue":"12","key":"1492_CR93","doi-asserted-by":"publisher","first-page":"e85951","DOI":"10.1371\/journal.pone.0085951","volume":"8","author":"Y Minakawa","year":"2013","unstructured":"Minakawa Y, Kasamatsu A, Koike H, Higo M, Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K. Kinesin family member 4A: a potential predictor for progression of human oral cancer. PLoS One. 2013; 8(12):e85951. https:\/\/doi.org\/10.1371\/journal.pone.0085951.","journal-title":"PLoS One"},{"issue":"1","key":"1492_CR94","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1515\/med-2020-0114","volume":"15","author":"Y Dong","year":"2020","unstructured":"Dong Y, Lu S, Wang Z, Liu L. CCTs as new biomarkers for the prognosis of head and neck squamous cancer. Open Med (Wars). 2020; 15(1):672-688. https:\/\/doi.org\/10.1515\/med-2020-0114.","journal-title":"Open Med"},{"issue":"2","key":"1492_CR95","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/jop.13116","volume":"50","author":"F Gao","year":"2021","unstructured":"Gao F, Li C, Zhao X, Xie J, Fang G, Li Y. CKS2 modulates cell-cycle progression of tongue squamous cell carcinoma cells partly via modulating the cellular distribution of DUTPase. J Oral Pathol Med. 2021; 50(2):175-182. https:\/\/doi.org\/10.1111\/jop.13116.","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"1492_CR96","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3892\/or.2017.5737","volume":"38","author":"CY Chuang","year":"2017","unstructured":"Chuang CY, Chang CP, Lee YJ, Lin WL, Chang WW, Wu JS, Cheng YW, Lee H, Li C. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells. Oncol Rep. 2017; 38(2):1115-1123. https:\/\/doi.org\/10.3892\/or.2017.5737.","journal-title":"Oncol Rep"},{"issue":"4","key":"1492_CR97","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/cancers14040855","volume":"14","author":"T Wu","year":"2022","unstructured":"Wu T, Jiao Z, Li Y, Su X, Yao F, Peng J, Chen W, Yang A. HPRT1 Promotes Chemoresistance in Oral Squamous Cell Carcinoma via Activating MMP1\/PI3K\/Akt Signaling Pathway. Cancers (Basel). 2022; 14(4):855. https:\/\/doi.org\/10.3390\/cancers14040855.","journal-title":"Cancers"},{"issue":"9","key":"1492_CR98","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/2211-5463.13250","volume":"11","author":"M Ahmadi","year":"2021","unstructured":"Ahmadi M, Eftekhari Kenzerki M, Akrami SM, Pashangzadeh S, Hajiesmaeili F, Rahnavard S, Habibipour L, Saffarzadeh N, Mousavi P. Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma. FEBS Open Bio. 2021;11(9):2525-2540. https:\/\/doi.org\/10.1002\/2211-5463.13250.\u00a0","journal-title":"FEBS Open Bio"},{"issue":"1","key":"1492_CR99","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/15384047.2022.2054244","volume":"23","author":"G Zhang","year":"2022","unstructured":"Zhang G, Zhao X, Liu W. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation. Cancer Biol Ther. 2022; 23(1):243-253. https:\/\/doi.org\/10.1080\/15384047.2022.2054244.","journal-title":"Cancer Biol Ther"},{"key":"1492_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.788084","volume":"11","author":"F Acker","year":"2021","unstructured":"Acker F, Stratmann J, Aspacher L, Nguyen NTT, Wagner S, Serve H, Wild PJ, Sebastian M. KRAS Mutations in Squamous Cell Carcinomas of the Lung. Front Oncol. 2021;11: https:\/\/doi.org\/10.3389\/fonc.2021.788084.","journal-title":"Front Oncol."},{"issue":"51","key":"1492_CR101","doi-asserted-by":"publisher","first-page":"85063","DOI":"10.18632\/oncotarget.13195","volume":"7","author":"J Vallejo-D\u00edaz","year":"2016","unstructured":"Vallejo-D\u00edaz J, Olazabal-Mor\u00e1n M, Cariaga-Mart\u00ednez AE, Pajares MJ, Flores JM, Pio R, Montuenga LM, Carrera AC. Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma. Oncotarget. 2016; 7(51):85063-85078. https:\/\/doi.org\/10.18632\/oncotarget.13195.","journal-title":"Oncotarget"},{"issue":"17","key":"1492_CR102","doi-asserted-by":"publisher","first-page":"6220","DOI":"10.3390\/ijms21176220","volume":"21","author":"N Attaran","year":"2020","unstructured":"Attaran N, Gu X, Coates PJ, F\u00e5hraeus R, Boldrup L, Wilms T, Wang L, Sgaramella N, Zborayova K, Nylander K. Downregulation of TAP1 in Tumor-Free Tongue Contralateral to Squamous Cell Carcinoma of the Oral Tongue, an Indicator of Better Survival. Int J Mol Sci. 2020; 21(17):6220. https:\/\/doi.org\/10.3390\/ijms21176220.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"1492_CR103","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1038\/s41388-018-0662-9","volume":"38","author":"VK Pidugu","year":"2019","unstructured":"Pidugu VK, Wu MM, Yen AH, Pidugu HB, Chang KW, Liu CJ, Lee TC. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling. Oncogene. 2019;38(17):3232\u2013247. https:\/\/doi.org\/10.1038\/s41388-018-0662-9.","journal-title":"Oncogene"},{"key":"1492_CR104","doi-asserted-by":"crossref","unstructured":"Lee TC, Pidugu VK, Wu MM, Liu CJ. IFIT1 and IFIT3 modulate the drug response via enhancing EGFR signaling and in human oral squamous cell carcinoma cells. In: Proceedings for Annual Meeting of The Japanese Pharmacological Society WCP2018 (The 18th World Congress of Basic and Clinical Pharmacology), pp. PO4\u20136, 2018, Japanese Pharmacological Society.","DOI":"10.1254\/jpssuppl.WCP2018.0_PO4-6-40"},{"key":"1492_CR105","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fonc.2019.00058","volume":"9","author":"N Sarmah","year":"2019","unstructured":"Sarmah N, Baruah MN, Baruah S. Immune Modulation in HLA-G Expressing Head and Neck Squamous Cell Carcinoma in Relation to Human Papilloma Virus Positivity: A Study From Northeast India. Front Oncol. 2019;9:58. https:\/\/doi.org\/10.3389\/fonc.2019.00058.","journal-title":"Front Oncol"},{"issue":"5","key":"1492_CR106","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.humimm.2022.02.006","volume":"83","author":"M Bora","year":"2022","unstructured":"Bora M, Sarmah N, Das B, Baruah MN, Deka G, Hazarika SG, Baruah S. A comparative study on regulation of HLA-G expression in bad obstetric history and in head and neck squamous cell carcinoma from Northeast India. Human Immunol. 2022;83(5):453\u20137. https:\/\/doi.org\/10.1016\/j.humimm.2022.02.006.","journal-title":"Human Immunol."},{"issue":"9","key":"1492_CR107","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.22034\/APJCP.2018.19.9.2527","volume":"19","author":"R Imani","year":"2018","unstructured":"Imani R, Seyedmajidi M, Ghasemi N, Moslemi D, Shafaee S, Bijani A. HLA-G Expression is Associated with an Unfavorable Prognosis of Oral Squamous Cell Carcinoma. Asian Pac J Cancer Prev. 2018;19(9):2527\u201333 \nhttps:\/\/doi.org\/10.22034\/APJCP.2018.19.9.2527\n.","journal-title":"Asian Pac J Cancer Prev."},{"issue":"1","key":"1492_CR108","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1186\/s12885-021-09058-y","volume":"21","author":"D Ou","year":"2021","unstructured":"Ou D, Wu Y. The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma. BMC Cancer. 2021;21(1):1327. https:\/\/doi.org\/10.1186\/s12885-021-09058-y.","journal-title":"BMC Cancer."},{"issue":"5","key":"1492_CR109","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1007\/s13277-013-1549-6","volume":"35","author":"M Rentoft","year":"2014","unstructured":"Rentoft M, Coates PJ, Loljung L, Wilms T, Laurell G, Nylander K. Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue. Tumour Biol. 2014;35(5):4191\u20138. https:\/\/doi.org\/10.1007\/s13277-013-1549-6.","journal-title":"Tumour Biol."},{"key":"1492_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.570736","volume":"10","author":"Y Li","year":"2021","unstructured":"Li Y, Wu T, Gong S, Zhou H, Yu L, Liang M, Shi R, Wu Z, Zhang J, Li S. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma. Front Oncol. 2021;10: https:\/\/doi.org\/10.3389\/fonc.2020.570736.","journal-title":"Front Oncol."},{"issue":"5","key":"1492_CR111","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/ajcp\/aqz205","volume":"153","author":"H Li","year":"2020","unstructured":"Li H, Yang LL, Wu CC, Xiao Y, Mao L, Chen L, Zhang WF, Sun ZJ. Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma. Am J Clin Pathol. 2020;153(5):618\u201329. https:\/\/doi.org\/10.1093\/ajcp\/aqz205.","journal-title":"Am J Clin Pathol."},{"issue":"2","key":"1492_CR112","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.7314\/apjcp.2013.14.2.1147","volume":"14","author":"RP Laljee","year":"2013","unstructured":"Laljee RP, Muddaiah S, Salagundi B, Cariappa PM, Indra AS, Sanjay V, Ramanathan A. Interferon stimulated gene-ISG15 is a potential diagnostic biomarker in oral squamous cell carcinomas. Asian Pac J Cancer Prev. 2013;14(2):1147\u201350. https:\/\/doi.org\/10.7314\/apjcp.2013.14.2.1147.","journal-title":"Asian Pac J Cancer Prev."},{"issue":"3","key":"1492_CR113","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.3892\/etm.2017.4720","volume":"14","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, He Y, Nie M, Cai W. Roles of miR-138 and ISG15 in oral squamous cell carcinoma. Exp Ther Med. 2017;14(3):2329\u201334. https:\/\/doi.org\/10.3892\/etm.2017.4720.","journal-title":"Exp Ther Med."},{"issue":"3","key":"1492_CR114","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1158\/1541-7786.MCR-05-0212","volume":"4","author":"CR Santos","year":"2006","unstructured":"Santos CR, Rodr\u00edguez-Pinilla M, Vega FM, Rodr\u00edguez-Peralto JL, Blanco S, Sevilla A, Valbuena A, Hern\u00e1ndez T, van Wijnen AJ, Li F, de Alava E, S\u00e1nchez-C\u00e9spedes M, Lazo PA. VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma. Mol Cancer Res. 2006;4(3):177\u201385. https:\/\/doi.org\/10.1158\/1541-7786.MCR-05-0212.","journal-title":"Mol Cancer Res."},{"key":"1492_CR115","doi-asserted-by":"publisher","first-page":"3138046","DOI":"10.1155\/2021\/3138046","volume":"2021","author":"X Cao","year":"2021","unstructured":"Cao X, Luan K, Yang J, Huang Y. Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma. Dis Markers. 2021;2021:3138046. https:\/\/doi.org\/10.1155\/2021\/3138046.","journal-title":"Dis Markers."},{"issue":"18","key":"1492_CR116","doi-asserted-by":"publisher","first-page":"6515","DOI":"10.1002\/cam4.4163","volume":"10","author":"J Wang","year":"2021","unstructured":"Wang J, Sun Z, Wang J, Tian Q, Huang R, Wang H, Wang X, Han F. Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis. Cancer Med. 2021;10(18):6515\u201333. https:\/\/doi.org\/10.1002\/cam4.4163.","journal-title":"Cancer Med."},{"key":"1492_CR117","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.oraloncology.2019.04.019","volume":"93","author":"G Troiano","year":"2019","unstructured":"Troiano G, Caponio VCA, Adipietro I, Tepedino M, Santoro R, Laino L, Lo Russo L, Cirillo N, Lo Muzio L. Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Oral Oncol. 2019;93:66\u201375. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.04.019.","journal-title":"Oral Oncol."},{"key":"1492_CR118","doi-asserted-by":"publisher","unstructured":"Kubota K, Moriyama M, Furukawa S, Rafiul HASM, Maruse Y, Jinno T, Tanaka A, Ohta M, Ishiguro N, Yamauchi M, Sakamoto M, Maehara T, Hayashida JN, Kawano S, Kiyoshima T, Nakamura S. CD163+CD204+ tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma. Sci Rep. 2017;7(1):1755. https:\/\/doi.org\/10.1038\/s41598-017-01661-z.","DOI":"10.1038\/s41598-017-01661-z"},{"key":"1492_CR119","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/838632","volume":"2014","author":"KF He","year":"2014","unstructured":"He KF, Zhang L, Huang CF, Ma SR, Wang YF, Wang WM, Zhao ZL, Liu B, Zhao YF, Zhang WF, Sun ZJ. CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma. Biomed Res Int. 2014;2014: 838632. https:\/\/doi.org\/10.1155\/2014\/838632.","journal-title":"Biomed Res Int."},{"issue":"26","key":"1492_CR120","doi-asserted-by":"publisher","first-page":"12044","DOI":"10.7150\/thno.47901","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang X, Dong Y, Zhao M, Ding L, Yang X, Jing Y, Song Y, Chen S, Hu Q, Ni Y. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system. Theranostics. 2020;10(26):12044\u201359. https:\/\/doi.org\/10.7150\/thno.47901.","journal-title":"Theranostics."},{"issue":"4","key":"1492_CR121","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/CM9.0000000000001776","volume":"135","author":"S Lu","year":"2021","unstructured":"Lu S, Li N, Peng Z, Lu Z, Tu X, Zhang W, Kang Y. Fc fragment of immunoglobulin G receptor IIa (FCGR2A) as a new potential prognostic biomarker of esophageal squamous cell carcinoma. Chin Med J (Engl). 2021;135(4):482\u20134. https:\/\/doi.org\/10.1097\/CM9.0000000000001776.","journal-title":"Chin Med J (Engl)."},{"key":"1492_CR122","doi-asserted-by":"publisher","first-page":"8874578","DOI":"10.1155\/2021\/8874578","volume":"2021","author":"Y Dai","year":"2021","unstructured":"Dai Y, Chen W, Huang J, Cui T. FCGR2A Could Function as a Prognostic Marker and Correlate with Immune Infiltration in Head and Neck Squamous Cell Carcinoma. Biomed Res Int. 2021;2021:8874578. https:\/\/doi.org\/10.1155\/2021\/8874578.","journal-title":"Biomed Res Int."},{"key":"1492_CR123","doi-asserted-by":"publisher","unstructured":"Magnes T, Melchardt T, Hufnagl C, Weiss L, Mittermair C, Neureiter D, Klieser E, Rinnerthaler G, Roesch S, Gaggl A, Greil R, Egle A. The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab. Pharmacogenomics J. 2018; 18(3):474-479. https:\/\/doi.org\/10.1038\/tpj.2017.37.","DOI":"10.1038\/tpj.2017.37"},{"issue":"9","key":"1492_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045228","volume":"7","author":"Md Santos","year":"2012","unstructured":"Santos Md, Mercante AMdC, Louro ID, Gon\u00e7alves AJ, Carvalho MBd, da Silva EHT, et al. HIF1-Alpha Expression Predicts Survival of Patients with Squamous Cell Carcinoma of the Oral Cavity. PLoS ONE. 2012;7(9): e45228. https:\/\/doi.org\/10.1371\/journal.pone.0045228.","journal-title":"PLoS ONE"},{"issue":"1","key":"1492_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-017-1163-y","volume":"15","author":"J Zhou","year":"2017","unstructured":"Zhou J, Huang S, Wang L, Yuan X, Dong Q, Zhang D, Wang X. Clinical and prognostic significance of HIF-1\u03b1 overexpression in oral squamous cell carcinoma: a meta-analysis. World J Surg Oncol. 2017;15(1):104. https:\/\/doi.org\/10.1186\/s12957-017-1163-y.","journal-title":"World J Surg Oncol"},{"key":"1492_CR126","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-2407-5-84","volume":"5","author":"T Fillies","year":"2005","unstructured":"Fillies T, Werkmeister R, van Diest PJ, Brandt B, Joos U, Buerger H. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer. 2005;5:84. https:\/\/doi.org\/10.1186\/1471-2407-5-84.","journal-title":"BMC Cancer."},{"issue":"9","key":"1492_CR127","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3978\/j.issn.2305-5839.2014.08.01","volume":"2","author":"J Liang","year":"2014","unstructured":"Liang J, Zhang Z, Liang L, Shen Y, Ouyang K. HIF-1\u03b1 regulated tongue squamous cell carcinoma cell growth via regulating VEGF expression in a xenograft model. Ann Transl Med. 2014;2(9):92. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2014.08.01.","journal-title":"Ann Transl Med."},{"issue":"10","key":"1492_CR128","doi-asserted-by":"publisher","first-page":"9487","DOI":"10.1007\/s13277-014-2482-z","volume":"35","author":"S Routray","year":"2014","unstructured":"Routray S. Caveolin-1 in oral squamous cell carcinoma microenvironment: an overview. Tumour Biol. 2014;35(10):9487\u201395. https:\/\/doi.org\/10.1007\/s13277-014-2482-z.","journal-title":"Tumour Biol."},{"issue":"39","key":"1492_CR129","doi-asserted-by":"publisher","first-page":"41884","DOI":"10.18632\/oncotarget.6099","volume":"6","author":"AC Jung","year":"2015","unstructured":"Jung AC, Ray AM, Ramolu L, Macabre C, Simon F, Noulet F, Blandin AF, Renner G, Lehmann M, Choulier L, Kessler H, Abecassis J, Dontenwill M, Martin S. Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties. Oncotarget. 2015;6(39):41884\u2013901. \nhttps:\/\/doi.org\/10.18632\/oncotarget.6099\n.","journal-title":"Oncotarget."},{"issue":"2","key":"1492_CR130","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2010.e20","volume":"54","author":"J Xue","year":"2010","unstructured":"Xue J, Chen H, Diao L, Chen X, Xia D. Expression of Caveolin-1 in tongue squamous cell carcinoma by quantum dots. Eur J Histochem. 2010;54(2):e20. https:\/\/doi.org\/10.4081\/ejh.2010.e20.","journal-title":"Eur J Histochem."},{"key":"1492_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.809589","volume":"12","author":"L Zhou","year":"2022","unstructured":"Zhou L, Li H, Cai H, Liu W, Pan E, Yu D, He S. Upregulation of IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression That Is Related to Cell Proliferation, Metastasis and Tumor-Infiltrating Immune Cells. Front Oncol. 2022;12:809589. https:\/\/doi.org\/10.3389\/fonc.2022.809589.","journal-title":"Front Oncol."},{"issue":"2","key":"1492_CR132","doi-asserted-by":"publisher","first-page":"BSR20212119","DOI":"10.1042\/BSR20212119","volume":"42","author":"X Wang","year":"2022","unstructured":"Wang X, Xu H, Zhou Z, Guo S, Chen R. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma. Biosci Rep. 2022; 42(2):BSR20212119. https:\/\/doi.org\/10.1042\/BSR20212119.","journal-title":"Biosci Rep"},{"key":"1492_CR133","doi-asserted-by":"crossref","unstructured":"Rapone B, Ferrara E. Vascular Endothelial\nGrowth Factor Expression in the Pathological\nAngiogenesis in Oral Squamous Cell\nCarcinoma. In: Sridharan G, Sukumaran\nA, Al-Ostwani AEO, editors. Oral Diseases.\nRijeka: IntechOpen; 2020","DOI":"10.5772\/intechopen.90924"},{"issue":"9","key":"1492_CR134","first-page":"3969","volume":"33","author":"ADS Almeida","year":"2013","unstructured":"dos Santos Almeida A, Oliveira DT, Pereira MC, Faustino SE, Nonogaki S, Carvalho AL, Kowalski LP. Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance. Anticancer Res. 2013; 33(9):3969-76.","journal-title":"Anticancer Res"},{"key":"1492_CR135","doi-asserted-by":"publisher","first-page":"101795","DOI":"10.1016\/j.tice.2022.101795","volume":"76","author":"J Na","year":"2022","unstructured":"Na J, Zhou W, Yin M, Hu Y, Ma X. GNA13 promotes the proliferation and migration of lung squamous cell carcinoma cells through regulating the PI3K\/AKT signaling pathway. Tissue Cell. 2022;76:101795. https:\/\/doi.org\/10.1016\/j.tice.2022.101795.","journal-title":"Tissue Cell"},{"issue":"2","key":"1492_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-014-0459-9","volume":"32","author":"Yn Liang","year":"2015","unstructured":"Liang YN, Liu Y, Meng Q, Li X, Wang F, Yao G, Wang L, Fu S, Tong D. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma. Med Oncol. 2015;32(2):459. https:\/\/doi.org\/10.1007\/s12032-014-0459-9.","journal-title":"Med Oncol"},{"issue":"4","key":"1492_CR137","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.3892\/ol.2018.9221","volume":"16","author":"M Wang","year":"2018","unstructured":"Wang M, Xie T, Wu Y, Yin Q, Xie S, Yao Q, Xiong J, Zhang Q. Identification of RFC5 as a novel potential prognostic biomarker in lung cancer through bioinformatics analysis. Oncol Lett. 2018;16(4):4201-210. https:\/\/doi.org\/10.3892\/ol.2018.9221.","journal-title":"Oncol Lett"},{"issue":"10","key":"1492_CR138","doi-asserted-by":"publisher","first-page":"e0164804","DOI":"10.1371\/journal.pone.0164804","volume":"11","author":"EA Simonik","year":"2016","unstructured":"Simonik EA, Cai Y, Kimmelshue KN, Brantley-Sieders DM, Loomans HA, Andl CD, Westlake GM, Youngblood VM, Chen J, Yarbrough WG, Brown BT, Nagarajan L, Brandt SJ. LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer). PLoS One. 2016;11(10):e0164804. https:\/\/doi.org\/10.1371\/journal.pone.0164804.","journal-title":"PLoS One"},{"issue":"3","key":"1492_CR139","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2559.2011.03765.x","volume":"58","author":"RA Kwong","year":"2011","unstructured":"Kwong RA, Scarlett CJ, Kalish LH, Cole IE, Kench JG, Sum EY, Musgrove EA, Henshall SM, Lindeman GJ, Biankin AV, Visvader JE, Sutherland RL. LMO4 expression in squamous cell carcinoma of the anterior tongue. Histopathology. 2011;58(3):477\u201380. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.03765.x.","journal-title":"Histopathology."},{"issue":"3","key":"1492_CR140","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/CCO.0000000000000513","volume":"31","author":"G van Caloen","year":"2019","unstructured":"van Caloen G, Machiels JP. Potential role of cyclin-dependent kinase 4\/6 inhibitors in the treatment of squamous cell carcinoma of the head and neck. Curr Opin Oncol. 2019;31(3):122\u201330. https:\/\/doi.org\/10.1097\/CCO.0000000000000513.","journal-title":"Curr Opin Oncol."},{"issue":"12","key":"1492_CR141","doi-asserted-by":"publisher","first-page":"14803","DOI":"10.18632\/oncotarget.7543","volume":"7","author":"BM Ku","year":"2016","unstructured":"Ku BM, Yi SY, Koh J, Bae YH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. The CDK4\/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma. Oncotarget. 2016;7(12):14803\u201313. \nhttps:\/\/doi.org\/10.18632\/oncotarget.7543\n.","journal-title":"Oncotarget."},{"issue":"15_suppl","key":"1492_CR142","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1200\/jco.2015.33.15_suppl.6063","volume":"33","author":"GJ Lourenco","year":"2015","unstructured":"Lourenco GJ, Nogueira GAS, Oliveira CBM, Marson FAL, Lopes-Aguiar L, Costa EFD, Lima TRP, Liutti VT, Leal F, Santos VA, Rinck JA, Lima CSP, MLH1, MSH2, MSH3 and EXO1 polymorphisms and head and neck squamous cell carcinoma risk and prognosis. Journal of Clinical Oncology. 2015;33(15_suppl):6063\u20136063. https:\/\/doi.org\/10.1200\/jco.2015.33.15_suppl.6063.","journal-title":"Journal of Clinical Oncology."},{"issue":"5","key":"1492_CR143","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1590\/1679-775720130206","volume":"21","author":"CS Pereira","year":"2013","unstructured":"Pereira CS, Oliveira MV, Barros LO, Bandeira GA, Santos SH, Basile JR, Guimar\u00e3es AL, De Paula AM. Low expression of MSH2 DNA repair protein is associated with poor prognosis in head and neck squamous cell carcinoma. J Appl Oral Sci. 2013;21(5):416\u201321. https:\/\/doi.org\/10.1590\/1679-775720130206.","journal-title":"J Appl Oral Sci."},{"issue":"14","key":"1492_CR144","first-page":"46","volume":"1","author":"Y Wang","year":"2017","unstructured":"Wang Y, Lu Z, Hu Z, Zheng A, Wang F, Xu Y, et al. The up-regulation of TANK-binding kinase 1 in head and neck squamous cell carcinoma. Differentiation. 2017;1(14):46\u20137.","journal-title":"Differentiation"},{"key":"1492_CR145","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.12659\/msm.905035","volume":"23","author":"H Zhang","year":"2017","unstructured":"Zhang H, Liu J, Fu X, Yang A. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis. Med Sci Monit. 2017;23:5924\u201332. \nhttps:\/\/doi.org\/10.12659\/msm.905035\n.","journal-title":"Med Sci Monit."},{"issue":"9","key":"1492_CR146","doi-asserted-by":"publisher","first-page":"e3035","DOI":"10.1038\/cddis.2017.433","volume":"8","author":"Y Yuan","year":"2017","unstructured":"Yuan Y, Xie X, Jiang Y, Wei Z, Wang P, Chen F, Li X, Sun C, Zhao H, Zeng X, Jiang L, Zhou Y, Dan H, Feng M, Liu R, Wang Z, Chen Q. LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS. Cell Death Dis. 2017; 8(9):e3035. https:\/\/doi.org\/10.1038\/cddis.2017.433.\u00a0","journal-title":"Cell Death Dis"},{"issue":"6","key":"1492_CR147","doi-asserted-by":"publisher","first-page":"e22899","DOI":"10.1002\/jcla.22899","volume":"33","author":"Z Shen","year":"2019","unstructured":"Shen Z, Hu Y, Zhou C, Yuan J, Xu J, Hao W, Deng H, Ye D. ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma. J Clin Lab Anal. 2019;33(6):e22899. https:\/\/doi.org\/10.1002\/jcla.22899.\u00a0","journal-title":"J Clin Lab Anal"},{"issue":"18","key":"1492_CR148","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.7150\/jca.25666","volume":"9","author":"R Fukushima","year":"2018","unstructured":"Fukushima R, Kasamatsu A, Nakashima D, Higo M, Fushimi K, Kasama H, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K. Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer. J Cancer. 2018;9(18):3326\u20133333. https:\/\/doi.org\/10.7150\/jca.25666.","journal-title":"J Cancer"},{"issue":"1","key":"1492_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-021-01898-7","volume":"40","author":"SH Wang","year":"2021","unstructured":"Wang SH, Chen YL, Hsiao JR, Tsai FY, Jiang SS, Lee AY, Tsai HJ, Chen YW. Insulin-like growth factor binding protein 3 promotes radiosensitivity of oral squamous cell carcinoma cells via positive feedback on NF-$$\\kappa$$B\/IL-6\/ROS signaling. J Exp Clin Cancer Res. 2021;40(1):95. https:\/\/doi.org\/10.1186\/s13046-021-01898-7.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1492_CR150","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/cancers12020494","volume":"12","author":"J Sakata","year":"2020","unstructured":"Sakata J, Hirosue A, Yoshida R, Matsuoka Y, Kawahara K, Arita H, Nakashima H, Yamamoto T, Nagata M, Kawaguchi S, Gohara S, Nagao Y, Yamana K, Toya R, Murakami R, Kuwahara Y, Fukumoto M, Nakayama H.Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma. Cancers (Basel). 2020;12(2):494. https:\/\/doi.org\/10.3390\/cancers12020494.","journal-title":"Cancers"},{"key":"1492_CR151","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/froh.2021.638213","volume":"2","author":"K Hano","year":"2021","unstructured":"Hano K, Hatano K, Saigo C, Kito Y, Shibata T, Takeuchi T. Combination of Clptm1L and TMEM207 Expression as a Robust Prognostic Marker in Oral Squamous Cell Carcinoma. Frontiers in Oral Health.\u00a02021; 2:638213. https:\/\/doi.org\/10.3389\/froh.2021.638213.","journal-title":"Front Oral Health"},{"key":"1492_CR152","doi-asserted-by":"publisher","first-page":"096368972110459","DOI":"10.1177\/09636897211045970","volume":"30","author":"Y Hou","year":"2021","unstructured":"Hou Y, Xue F, Fu Y, Feng G, Wang R, Yuan H. CLPTM1L Is a Novel Putative Oncogene Promoting Tumorigenesis in Oral Squamous Cell Carcinoma. Cell Transplant. 2021;30:09636897211045970. https:\/\/doi.org\/10.1177\/09636897211045970.","journal-title":"Cell Transplant"},{"issue":"3","key":"1492_CR153","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3892\/or.2010.1131","volume":"25","author":"S Iwasawa","year":"2011","unstructured":"Iwasawa S, Yamano Y, Takiguchi Y, Tanzawa H, Tatsumi K, Uzawa K. Upregulation of thioredoxin reductase 1 in human oral squamous cell carcinoma. Oncol Rep. 2011;25(3):637\u201344. https:\/\/doi.org\/10.3892\/or.2010.1131.","journal-title":"Oncol Rep"},{"key":"1492_CR154","doi-asserted-by":"publisher","unstructured":"Feng J, Han B, Yu C, Shen C, Wen Z. Co-expression Network Identification and Clinical Prognostic Evaluation of Hub Genes in Head and Neck Squamous Cell Carcinoma. Research Square; 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-77378\/v1.","DOI":"10.21203\/rs.3.rs-77378\/v1"},{"issue":"10","key":"1492_CR155","doi-asserted-by":"publisher","first-page":"e0164870","DOI":"10.1371\/journal.pone.0164870","volume":"11","author":"HT Chien","year":"2016","unstructured":"Chien HT, Cheng SD, Chuang WY, Liao CT, Wang HM, Huang SF. Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas. PLoS One. 2016;11(10):e0164870. https:\/\/doi.org\/10.1371\/journal.pone.0164870.","journal-title":"PLoS One"},{"issue":"9","key":"1492_CR156","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/cancers12092393","volume":"12","author":"M\u00c1 Gonz\u00e1lez-Moles","year":"2020","unstructured":"Gonz\u00e1lez-Moles M\u00c1, Ay\u00e9n \u00c1, Gonz\u00e1lez-Ruiz I, de Porras-Carrique T, Gonz\u00e1lez-Ruiz L, Ruiz-\u00c1vila I, Ramos-Garc\u00eda P. Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancers (Basel). 2020;12(9):2393. https:\/\/doi.org\/10.3390\/cancers12092393.","journal-title":"Cancers"},{"issue":"6","key":"1492_CR157","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1177\/0194599811435052","volume":"146","author":"JJ Rasamny","year":"2012","unstructured":"Rasamny JJ, Allak A, Krook KA, Jo VY, Policarpio-Nicolas ML, Sumner HM, Moskaluk CA, Frierson HF Jr, Jameson MJ. Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2012;146(6):923\u201331. https:\/\/doi.org\/10.1177\/0194599811435052.","journal-title":"Otolaryngol-Head Neck Surg"},{"issue":"5","key":"1492_CR158","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00262-021-03059-3","volume":"71","author":"MW Knitz","year":"2022","unstructured":"Knitz MW, Darragh LB, Bickett TE, Bhatia S, Bukkapatnam S, Gadwa J, Piper M, Corbo S, Nguyen D, Van Court B, Oweida A, Karam SD. Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma. Cancer Immunol Immunother. 2022;71(5):1049\u201361. https:\/\/doi.org\/10.1007\/s00262-021-03059-3.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"1492_CR159","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/jnci\/djj020","volume":"98","author":"S Xi","year":"2006","unstructured":"Xi S, Dyer KF, Kimak M, Zhang Q, Gooding WE, Chaillet JR, Chai RL, Ferrell RE, Zamboni B, Hunt J, Grandis JR. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst. 2006;98(3):181\u20139. https:\/\/doi.org\/10.1093\/jnci\/djj020.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"1492_CR160","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.21873\/anticanres.13593","volume":"39","author":"C Tomasovic-Loncaric","year":"2019","unstructured":"Tomasovic-Loncaric C, Fucic A, Andabak A, Andabak M, Ceppi M, Bruzzone M, Vrdoljak D, Vucicevic-Boras V. Androgen Receptor as a Biomarker of Oral Squamous Cell Carcinoma Progression Risk. Anticancer Res. 2019;39(8):4285\u2013289. https:\/\/doi.org\/10.21873\/anticanres.13593.","journal-title":"Anticancer Res"},{"key":"1492_CR161","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.2147\/OTT.S200718","volume":"12","author":"X Liu","year":"2019","unstructured":"Liu X, Qing S, Che K, Li L, Liao X. Androgen receptor promotes oral squamous cell carcinoma cell migration by increasing EGFR phosphorylation. Onco Targets Ther. 2019;12:4245\u2013252. https:\/\/doi.org\/10.2147\/OTT.S200718.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"1492_CR162","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/09674845.2014.11669972","volume":"71","author":"D Kordi-Tamandani","year":"2014","unstructured":"Kordi-Tamandani D, Sabers E, Jamali S, Rigi Ladiz M. ERK and RAF1 genes: analysis of methylation and expression profiles in patients with oral squamous cell carcinoma. Br J Biomed Sci. 2014;71(3):100\u20133. https:\/\/doi.org\/10.1080\/09674845.2014.11669972.","journal-title":"Br J Biomed Sci"},{"issue":"1","key":"1492_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-015-0300-x","volume":"14","author":"R Mishra","year":"2015","unstructured":"Mishra R, Nagini S, Rana A. Expression and inactivation of glycogen synthase kinase 3 alpha\/beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression. Mol Cancer. 2015;14(1):20. https:\/\/doi.org\/10.1186\/s12943-015-0300-x.","journal-title":"Mol Cancer"},{"issue":"6","key":"1492_CR164","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00428-018-2318-0","volume":"472","author":"FS Matsuo","year":"2018","unstructured":"Matsuo FS, Andrade MF, Loyola AM, da Silva SJ, Silva MJB, Cardoso SV, et al. Pathologic significance of AKT, mTOR, and GSK3$$\\beta$$ proteins in oral squamous cell carcinoma-affected patients. Virchows Arch. 2018;472(6):983\u2013997. https:\/\/doi.org\/10.1007\/s00428-018-2318-0.","journal-title":"Virchows Arch"},{"issue":"1","key":"1492_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-55208-5","volume":"9","author":"AP Jain","year":"2019","unstructured":"Jain AP, Patel K, Pinto S, Radhakrishnan A, Nanjappa V, Kumar M, Raja R, Patil AH, Kumari A, Manoharan M, Karunakaran C, Murugan S, Keshava Prasad TS, Chang X, Mathur PP, Kumar P, Gupta R, Gupta R, Khanna-Gupta A, Sidransky D, Chatterjee A, Gowda H. MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma. Sci Rep. 2019;9(1):18793. https:\/\/doi.org\/10.1038\/s41598-019-55208-5.","journal-title":"Sci Rep"},{"key":"1492_CR166","doi-asserted-by":"publisher","first-page":"100277","DOI":"10.1016\/j.imu.2019.100277","volume":"18","author":"P Patowary","year":"2020","unstructured":"Patowary P, Bhattacharyya DK, Barah P. Identifying critical genes in esophageal squamous cell carcinoma using an ensemble approach. Inf Med Unlock. 2020;18:100277. https:\/\/doi.org\/10.1016\/j.imu.2019.100277.","journal-title":"Inf Med Unlock"}],"container-title":["SN Computer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42979-022-01492-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42979-022-01492-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42979-022-01492-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:38:16Z","timestamp":1744209496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42979-022-01492-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":166,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["1492"],"URL":"https:\/\/doi.org\/10.1007\/s42979-022-01492-4","relation":{},"ISSN":["2661-8907"],"issn-type":[{"type":"electronic","value":"2661-8907"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"31 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On the behalf of all authors, the corresponding authors states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"114"}}